コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 se model of Streptococcus pneumoniae-induced empyema.
2 etic joint infections as well bacteremia and empyema.
3 oscopic cholecystectomy due to a gallbladder empyema.
4 ly greater for patients with SSIs other than empyema.
5 a first diagnosis of sepsis, meningitis, or empyema.
6 patient in the intervention group developed empyema.
7 tients, possibly leading to lung abscess and empyema.
8 herapy and open thoracotomy in children with empyema.
9 pleural effusions, which rarely progress to empyema.
10 nase and VATS for the treatment of childhood empyema.
11 ce base to guide the management of childhood empyema.
12 ious mononucleosis complicated by unilateral empyema.
13 rm the best management approach in childhood empyema.
14 urgery (VATS) for the treatment of childhood empyema.
15 is, cellulitis at the thoracoscopy site, and empyema.
16 rtmentalized chemokine response in bacterial empyema.
17 l space, and impaired bacterial clearance in empyema.
18 and pulmonary nodules for 6 years developed empyema.
19 17% [7-27] in those aged 2-4 years) and for empyema (50% [95% CI 22-68] for children age <2 years, 4
20 thorax, paravertebral abscesses and epidural empyemas, abscess between adjacent vertebral bodies, abs
21 se, non-invasive pneumococcal pneumonia, and empyema (all coded by International Classification of Di
25 rainage of complicated pleural effusions and empyemas and it is the most effective drug in myocardial
30 sisted thoracic debridement in children with empyema compared with traditional therapy, as it decreas
31 ized with cCAP requiring pleural effusion or empyema drainage at Children's Hospital Colorado between
33 TPE, 30 patients with MPE, 14 patients with empyema (EMP) and 14 patients with parapneumonic effusio
34 trial fibrillation in 42, chylothorax in 24, Empyema in 23, pneumonia in 21, Hemothorax in 12 and pul
35 Legionella feeleii serotype 2 pneumonia with empyema in a man with chronic lymphocytic leukemia and d
36 ditional management of pleural effusions and empyema in children, resulting in decreasing reliance on
39 s developed that closely resembles bacterial empyema in patients infected with human immunodeficiency
40 pyema necessitatis is a rare complication of empyema in which the pleural infection spreads outside o
42 pleural fluid of rabbits that had undergone empyema induction, as fibrosis of the pleural space deve
45 (n = 28), pleural effusion (n = 13), pleural empyema (n = 4), lung abscess (n = 7), pericarditis (n =
49 rely been reported as the causative agent of empyema necessitatis, with the majority of S. aureus iso
50 l complications (eg, parapneumonic effusion, empyema, necrotising pneumonia, and lung abscess) and sy
51 pneumonitis, lung abscess, and occasionally empyema of mixed bacterial etiology (Staphylococcus spec
53 g, PAL was associated with increased odds of empyema (OR = 8.5; P < 0.001), requirement for additiona
54 5% confidence interval (CI),7.94-19.18]} and empyema, [OR 11.66 (95% CI, 7.31-18.63)] were associated
56 to the treatment of common problems such as empyema, pneumothorax, and lung biopsy has significantly
57 ah had a high rate of pediatric pneumococcal empyema (PPE) prior to licensure of the pneumococcal con
60 newly identified target for amelioration of empyema-related pleural fibrosis and provide a strong ra
61 of the admission, disease focus (meningitis, empyema, sepsis, or respiratory disease) and case fatali
62 sease due to nonvaccine serotypes, including empyema; the emergence of multidrug, including ceftriaxo